Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Udenafil for BPH and ED in Mexican Patients
NCT01967251Phase 2Withdrawn
- Sponsor
- Takeda
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of udenafil in benign prostatic hyperplasia (BPH), erectile dysfunction (ED), sponsored by Takeda. Planned start Sep 2015; status: withdrawn.
02
Drugs
udenafil
03
Conditions
benign prostatic hyperplasia (BPH)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01967251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967251.